DGDominika Galińska

Dominika Galińska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dominika Galińska has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient-Reported Outcomes Following Beta-Lactam Antibiotic Allergy Delabeling in Allergy Work-Up

    by Michał Powietrzyński, Jan Romantowski, Julia Glińska, Ilona Iwaszko, Joanna Pawlik, Nicola Le, Alicja Miecznikowska, Dominika Galińska, Maja Kozielec, Kaja Kozielec, et al.

    Background: Beta-lactam antibiotic allergy is one of the most frequently reported drug hypersensitivities. True allergy is rarely confirmed. Inaccurate labeling leads to unnecessary avoidance of beta-lactams, antimicrobial resistance, and increased healthcare costs. Delabeling is mainly evaluated using electronic databases, whereas patient perceptions, quality of life, and real-world barriers remain uncertain. Methods: This cross-sectional, questionnaire-based study included 96 adults with a reported history of beta-lactam hypersensitivity: 46 after successful specialist delabeling and 50 before specialist evaluation. Structured telephone interviews assessed diagnostic pathways, perceived correctness of diagnosis or exclusion, confidence in beta-lactam safety, antibiotic use, and symptom recurrence. Quality of life was assessed using the WHOQOL-BREF questionnaire. Results: Perceived safety of beta-lactam antibiotics was significantly higher in the delabeled group than in the non-delabeled group (7.37 vs. 2.40; p < 0.001). WHOQOL-BREF scores were similar between groups, except for a small difference in the Environment domain, favoring delabeled (p = 0.029) patients. Among delabeled patients, 57% required antibiotics during follow-up; of these, 65% received beta-lactams. In 35% of cases with an indication, physicians withheld beta-lactams despite documented delabeling. Self-reported mild cutaneous symptoms occurred in 18% of patients re-exposed to beta-lactam antibiotics despite delabeling; the significance of this finding needs to be assessed in the future. Conclusions: Patients who underwent beta-lactam allergy delabeling reported greater perceived safety regarding the use of beta-lactam antibiotics, while no significant differences in quality of life were observed. Persistent reluctance among patients and physicians may, however, limit the real-world benefits of delabeling.

  • Open Access

    DIETARY SUPPLEMENTS AND HERBAL PRODUCTS DURING ANTICANCER TREATMENT: PREVALENCE, INTERACTIONS AND THE PROBLEM OF NON-DISCLOSURE. A NARRATIVE REVIEW

    by Agata Kotlowska, Julia Lenkiewicz, Wiktoria Napiórkowska, Marcin Trzciński, Oliwia Lenkiewicz, Aleksandra Izabela Masłowska, Zuzanna Chmielewska, Anna Gwóźdź-Broczkowska, Gabriela Luba, Dominika Galińska

    Objectives: Dietary supplements and herbal products are widely used by patients undergoing anticancer treatment, and a considerable proportion of this use is never mentioned to their physician. This review summarises current evidence on the prevalence of such use, the pharmacological basis of interactions with anticancer agents, and the factors underlying non-disclosure on the part of both patients and clinicians. Methods: PubMed/MEDLINE and Google Scholar were searched for publications from January 2011, and July 2026, using combinations of terms relating to dietary supplements, herbal medicine, oncological treatment, herb–drug interactions and physician–patient communication. Priority was given to systematic reviews, meta-analyses and studies conducted in populations receiving anticancer treatment. Key findings: Reported prevalence varies widely between studies, depending on which products are counted and on the populations examined. Interactions arise principally through effects on drug metabolism and transport. Patients most often cite the absence of any question from the clinician as their reason for not disclosing; clinicians, in turn, describe their own knowledge of these products as insufficient. Training programmes have been developed to address this, but their effectiveness has yet to be established. Conclusions: Interactions between anticancer agents and dietary supplements or herbal products may be clinically relevant, yet often go unrecognised because their use is not disclosed. Non-disclosure is better understood as a feature of the consultation than as a behaviour of the patient. Two forms of intervention follow: strengthening clinicians' competence, and making enquiry about supplement use routine and free of judgement.

  • Open Access

    DOES THE 'QUEEN OF SPICES' LIVE UP TO ITS NAME? THE THERAPEUTIC POTENTIAL OF ELETTARIA CARDAMOMUM: A NARRATIVE REVIEW OF CURRENT EVIDENCE AND MOLECULAR MECHANISMS

    by Weronika Praska, Dominika Galińska, Natalia Domańska, Anna Roman, Joanna Zajączkowska, Natalia Marzec, Natalia Krupa, Aleksandra Marzec, Małgorzata Cherek, Stanisław Maria WardęCki

    Background: Green cardamom is the dried fruit of the herbaceous plant Elettaria cardamomum, originating from India. Due to its rich heritage in Ayurvedic medicine, mostly as a respiratory and digestive aid, as well as its distinct flavour, it has been historically known as the „Queen of Spices”. Despite its comprehensive pharmacological profile, green cardamom is frequently overshadowed by other functional spices, such as turmeric or cinnamon. Purpose: This narrative review aims to evaluate current evidence on green cardamom’s clinical therapeutic efficacy, with emphasis on metabolic, cardiovascular and gastrointestinal health, as well as potential anti-cancer and neuroprotective properties. Methods: A comprehensive review of literature was performed, using databases such as PubMed and Google Scholar. Relevant articles were found, including human clinical trials, animal models, in vitro studies, meta-analyses and systematic reviews. Results: Current evidence suggests that green cardamom’s therapeutic effects are primarily mediated through antioxidant and anti-inflammatory pathways. In metabolic and cardiovascular contexts, cardamom consistently improves insulin resistance, endothelial function, triglyceride levels and provides cardioprotection during ischemic events. However, human clinical data regarding its effects on obesity indexes and total cholesterol remain inconsistent. Gastrointestinally, the spice acts as both a spasmogenic and spasmolytic agent and offers protection against gastric ulcers. Oncological research highlights cardamom’s selective cytotoxicity, particularly against triple-negative breast cancer. In in vitro and animal models, the spice has shown promising results in management of Alzheimer’s disease and anxiety. Furthermore, its essential oil exhibits broad-spectrum antimicrobial activity.

  • Open Access

    MORINGA OLEIFERA LEAF EXTRACT IN MUSCLE WASTING AND SKELETAL MUSCLE DISORDERS: MECHANISMS, EVIDENCE, AND THERAPEUTIC POTENTIAL—A NARRATIVE REVIEW

    by Joanna Zajączkowska, Stanisław Maria WardęCki, Natalia Domańska, Dominika Galińska, Natalia Krupa, Aleksandra Marzec, Małgorzata Cherek, Weronika Praska, Anna Roman, Natalia Marzec

    Background: Skeletal muscle wasting accompanies ageing, malnutrition, glucocorticoid exposure, chronic disease, denervation, systemic inflammation, and prolonged inactivity. Interest in accessible plant-derived nutritional interventions has therefore expanded. Moringa oleifera leaves contain polyphenols, flavonoids, glucosinolates, isothiocyanates, and nutrients that may influence oxidative metabolism, redox balance, inflammation, and protein turnover. Objective: To synthesize evidence on M. oleifera leaf-derived preparations in muscle mass loss, impaired muscle function, fatigue, and skeletal muscle disorders, while defining the translational limitations of the literature. Methods: PubMed/MEDLINE and Google Scholar were searched for English-language, peer-reviewed publications from January 2016 through July 22, 2026. Cell studies, animal experiments, human studies, and reviews were considered. Claims were extracted from full texts when available; studies available only as abstracts or publisher previews were interpreted strictly within those limits. Results: Mechanistic studies in C2C12 cells consistently indicate modulation of Nrf2/HO-1 antioxidant signaling, glutathione homeostasis, SIRT1–PPARα-associated oxidative metabolism, and protection from hydrogen-peroxide stress. Animal studies report improved endurance or functional recovery and changes in inflammatory, fibrotic, apoptotic, mitochondrial, and protein-degradation markers; a 2026 study in mdx mice reported a partial functional and biochemical signal without uniform morphological benefit. Four small human performance studies were heterogeneous and did not evaluate patients with muscle wasting. Conclusions: M. oleifera leaf-derived preparations are biologically plausible candidates for further muscle research, but current evidence is predominantly preclinical, heterogeneous, and insufficient to support treatment recommendations for sarcopenia, cachexia, or other muscle-wasting disorders. Standardized products and adequately powered clinical trials are required.

  • Open Access

    HERICIUM ERINACEUS AND COGNITIVE ENHANCEMENT IN HEALTHY YOUNG ADULTS: A NARRATIVE REVIEW

    by Stanislaw Maria Wardecki, Joanna Zajączkowska, Natalia Marzec, Natalia Domańska, Weronika Praska, Anna Roman, Natalia Krupa, Aleksandra Marzec, Małgorzata Cherek, Dominika Galińska

    Background: Hericium erinaceus (lion's mane mushroom) has been investigated as a potential cognitive enhancer, partly because preclinical studies link selected constituents to neurotrophic signaling. The clinical relevance of these mechanisms in cognitively intact young adults remains uncertain. Objective: This narrative review evaluates human and mechanistic evidence relevant to cognitive enhancement by lion's mane, with emphasis on healthy young adults. Methods: Targeted searches of biomedical databases, publisher websites, and reference lists identified human trials, mechanistic studies, and contextual reviews available through June 2026. Results: Four studies directly examined healthy young or college-age adults. Acute studies reported changes in selected outcomes, including Stroop completion time, serial subtraction attempts, reaction-time measures, and pegboard performance. These findings were not consistent across cognitive domains or studies, and some reflected changes over time within the lion's mane condition rather than a clear advantage over placebo. A four-week college-age study found no cognitive benefit. More favorable results in older adults and people with cognitive impairment concern support of impaired function rather than enhancement above an intact baseline. Preclinical evidence most consistently supports nerve growth factor-related activity, whereas evidence involving brain-derived neurotrophic factor remains less developed and largely experimental. Conclusions: Current evidence does not support broad claims that lion's mane improves cognition or memory in healthy young adults. Larger randomized trials using chemically characterized preparations, prespecified cognitive outcomes, and prospective mechanistic biomarkers are required.

  • Open Access

    NARRATIVE REVIEW: LAPAROSCOPIC VS OPEN REPAIR OF INGUINAL HERNIAS IN ATHLETES: CLINICAL OUTCOMES AND RETURN TO SPORT

    by Natalia Krupa, Aleksandra Marzec, Dominika Galińska, Natalia Domańska, Anna Roman, Joanna Zajączkowska, Natalia Marzec, Małgorzata Cherek, Weronika Praska, Stanisław WardęCki

    Background: Inguinal hernias are super common, especially in active folks like athletes and gym-goers. They can really mess things up – causing pain, tanking your performance, and sidelining you from sports for weeks. If rest, physical therapy, or other conservative fixes don't cut it, surgery's usually the best bet to get you back in the game. There are two main surgical routes: open surgery (the classic approach) and laparoscopic surgery (the minimally invasive one). Both work well, but which one's right for you depends on factors like your hernia size, your activity level, and what your surgeon recommends. Goal: This narrative review compares laparoscopic and open inguinal hernia treatment in athletes, emphasizing clinical results, complications, and timetables for return to sport. Methods: A narrative literature review was performed using PubMed and Google Scholar. Studies were identified using combinations of relevant keywords, including “inguinal hernia”, “laparoscopic repair”, “open repair”, and “athletes”. Clinical studies, systematic reviews, and guidelines published primarily within the last 10 years were included. A qualitative synthesis was performed. Results: Available evidence suggests that laparoscopic repair may be associated with reduced postoperative pain and earlier functional recovery compared with open repair. Long-term outcomes, including recurrence rates, appear comparable between techniques. However, evidence specifically addressing athletic populations remains limited and heterogeneous. Conclusions: Both surgical techniques are effective and safe. Laparoscopic repair may offer advantages in early recovery and return to sport. Surgical decision-making should be individualized.

  • Open Access

    THERAPEUTIC APPLICATIONS OF MANUKA HONEY IN MODERN MEDICINE: A NARRATIVE REVIEW OF CLINICAL EFFICACY AND SAFETY

    by Natalia Domańska, Dominika Galińska, Joanna Zajączkowska, Natalia Marzec, Aleksandra Marzec, Anna Roman, Natalia Krupa, Małgorzata Cherek, Weronika Praska, Stanisław Maria WardęCki

    Introduction: Manuka honey, derived from the nectar of the Manuka tree, is recognized in medicine for its unique non-peroxide antibacterial activity. This property stems from high levels of methylglyoxal, formed naturally during honey ripening. Amidst rising antibiotic resistance, such natural agents are being evaluated for their multi-target mechanisms in clinical practice. Purpose: This review evaluates the clinical efficacy and safety of medical-grade Manuka honey across various clinical fields, including surgical and non-surgical specialties, based on recent evidence-based research and biochemical data. Methods: A critical evaluation was performed using electronic databases, focusing on randomized clinical trials, case reports, and systematic reviews published in the last two decades. Sixteen primary sources provided data for this synthesis, evaluating Manuka honey as both a primary and adjunctive treatment. Results: Clinical evidence indicates that Manuka honey improves symptoms of dry eye and blepharitis by reducing colonization and stabilizing the tear film. In oncological care, it helps manage radiation-induced oral mucositis and xerostomia. It also shows success in treating chronic rhinosinusitis and wounds by disrupting biofilms and promoting regeneration. Its antibacterial properties benefit oral hygiene and folliculitis treatment. Conclusion: Manuka honey is a versatile and safe therapeutic agent. It is intended to supplement conventional systemic antibiotics rather than replace them, serving as a biological adjunct for chronic inflammatory conditions, specialized wound care, and the protection of mucosal surfaces during intensive oncological treatments.

  • Open Access

    FROM CAFFEINE TO CATECHINS: A NARRATIVE REVIEW OF THE COMPARATIVE AND SYNERGISTIC EFFECTS OF COFFEE AND MATCHA ON HUMAN HEALTH

    by Małgorzata Cherek, Natalia Marzec, Natalia Krupa, Natalia Domańska, Dominika Galińska, Anna Roman, Aleksandra Marzec, Stanisław WardęCki, Joanna Zajączkowska, Weronika Praska

    This review compares the effects and benefits of consuming two of the most popular hot beverages: matcha tea and coffee. Both of them have been consumed for centuries and are embedded in cultural, societal, and dietary practices worldwide. They contain various bioactives, including caffeine, L-theanine, and polyphenols, which confer neuroprotective, antioxidant, and stimulating effects. The presence of these compounds has led to increased scientific interest in their potential role in disease prevention and cognitive enhancement. Matcha is a finely ground powder obtained from green tea leaves (Camellia sinensis) and is traditionally utilized in Japanese tea ceremonies [5]. Its preparation method, which involves consuming the entire leaf, distinguishes it from other tea infusions. It’s rich in catechins, L-theanine, and caffeine, which collectively influence concentration and cognitive performance. Coffee, produced from roasted seeds of the Coffea plant (C. arabica or C. canephora), is high in caffeine and enhances alertness and cognitive function. Due to its widespread consumption, coffee has been extensively studied in both clinical and epidemiological settings Purpose: This review examines the beneficial effects of hot beverages as reported in studies and by beverage companies. In addition, it aims to provide a comparative perspective that highlights both similarities and differences in their bioactive profiles. While there is abundant research on coffee, studies on matcha tea are limited, underscoring its potential for further investigation. Methods: A comprehensive literature review was conducted using the electronic databases PubMed and Google Scholar. Search strategies included a combination of keywords related to caffeine, catechins, and cognitive or metabolic outcomes. Relevant articles from the past decade were identified, including meta-analyses, controlled trials, opinion pieces, and review articles. Only studies available in English and focusing on human or relevant animal models were considered.

  • Open Access

    CONTEXT-DEPENDENT EFFECTS OF VITAMIN D SUPPLEMENTATION ON BONE MINERAL DENSITY AND FRACTURE RISK: A NARRATIVE REVIEW ACROSS CLINICAL AND ATHLETIC POPULATIONS

    by Anna Roman, Stanisław Maria WardęCki, Joanna Zajączkowska, Natalia Marzec, Natalia Domańska, Dominika Galińska, Natalia Krupa, Aleksandra Marzec, Małgorzata Cherek, Weronika Praska

    Background: Vitamin D plays a well-established role in calcium absorption and bone metabolism, yet its effectiveness as a supplementation strategy has been increasingly questioned, with fractures representing the most serious complication of deficiency-related bone loss. These questions are particularly relevant in athletic populations, where vitamin D insufficiency is widespread and has been linked to bone stress injuries despite high levels of physical activity. Objective: This narrative review synthesises evidence from both clinical and athletic populations to identify when and for whom vitamin D supplementation is most likely to confer measurable skeletal benefit. Results: In athletic populations, vitamin D deficiency is widespread yet does not consistently impair bone mineral density, most likely because mechanical loading compensates for its effects. In genuinely deficient athletes, targeted supplementation may help reduce stress fracture risk, though randomised trial evidence remains limited. In clinical populations, vitamin D alone does not reliably reduce fracture risk or improve bone mineral density in unselected individuals. More consistent benefits emerge when calcium is combined with vitamin D, particularly in postmenopausal women, institutionalised elderly, and patients on pharmacological osteoporosis treatment, which provides useful comparative context for understanding the conditions under which supplementation is most likely to benefit athletes and active individuals. Conclusions: The skeletal effects of vitamin D are highly context-dependent, influenced by baseline deficiency, calcium intake, physical activity, and population characteristics. Routine universal supplementation is not justified. A targeted approach based on confirmed deficiency and individual clinical context is recommended across both populations.

  • Open Access

    THE ROLE OF OMEGA-3 FATTY ACIDS IN SLEEP DEPRIVATION AND MENTAL HEALT: A NARRATIVE REVIEW

    by Dominika Galińska, Natalia Domańska, Anna Roman, Joanna Zajączkowska, Natalia Marzec, Natalia Krupa, Aleksandra Marzec, Małgorzata Cherek, Weronika Praska, Stanisław Maria WardęCki

    Objectives: The influence of omega-3 fatty acids on sleep disorders and mental health functio-ning constitutes a complex research problem, necessitating a clear distinction between their the-rapeutic potential and alleged prophylactic properties. Unrecognized neurochemical imbalances and neuroinflammatory states may contribute to the development of depression, anxiety, and insomnia, making a rigorous assessment of supplementation efficacy essential for safe and accu-rate therapeutic decisions. Our objective is to present a comprehensive synthesis of current evi-dence regarding the mechanisms of action, clinical effectiveness, and limitations of omega-3 fatty acid use in the context of sleep quality and mental health. Methods: Based on the available sources, a narrative literature review was conducted, focusing on studies analyzing the influence of polyunsaturated fatty acids (primarily EPA and DHA) on the nervous system. The evidence was synthesized based on observational and experimental studies, meta-analyses of randomized clinical trials, and current clinical guidelines (including those regarding the use of nutraceuticals in the treatment of psychiatric disorders). Key findings: Omega-3 fatty acids, specifically DHA and EPA, constitute key modulators of cell membrane structure, neurotransmission (dopaminergic and serotonergic systems), and the melatonin secretion rhythm. Current evidence strongly supports their use as adjunctive therapy in the treatment of depressive disorders and the alleviation of anxiety, particularly in patients with elevated inflammation and oxidative stress. However, they are not recommended as mo-notherapy. There is also a lack of evidence confirming their efficacy in the primary prevention of depression in healthy individuals. Accumulated data indicate that improvement in objective sleep parameters and mood stabilization require an individualized approach, and the therapeutic effect depends largely on the patient's baseline metabolic status. Conclusion: Omega-3 fatty acids may perform a significant corrective and supportive function in the treatment of mental disorders and sleep problems, acting as a stabilizer of pathological neurobiological changes rather than a universal mood enhancer. Integrated with appropriate cli-nical diagnostics, they allow for the safe support of standard pharmacotherapy. Future research should focus on determining optimal doses and EPA/DHA ratios, standardizing research proto-cols, and long-term evaluation in strictly selected clinical populations.